Biotech Eiger Says Ch. 11 Should Stay In Texas

By Yun Park · May 3, 2024, 4:20 PM EDT

Rare-disease treatment developer Eiger has urged a Texas bankruptcy judge to keep its Chapter 11 in the Dallas court despite an attempt by the U.S. Trustee's Office to have the case...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Eiger BioPharmaceuticals Inc. filed for Chapter 11 protection in Texas bankruptcy court with $53.1 million of debt and plans to sell its assets during the case.

Case Number

8:24-bk-80040

Judge

Stacey Jernigan

Venue

U.S. Bankruptcy Court for the Northern District of Texas

Capital Structure

Total Liabilities:

$53.1 million

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number

8:24-bk-80040

Court

Texas Northern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Yun